TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

LGM PHARMA

MetabolicImmunologyCardiovascular
Generics

LGM PHARMA is a generic drug manufacturer focused on Metabolic, Immunology, Cardiovascular. Key products include GLYCOPYRROLATE.

2001
Since
12
Drugs
-
Trials
65
Approved (2yr)

Key Drugs

HYDROCODONE BITARTRATE AND ASPIRIN
aspirin
Pain
1 indications · 2021

Recent Activity

GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
HYDROCODONE BITARTRATE AND ASPIRIN 2026-01-02
Labeling
GLYCOPYRROLATE 2025-12-23
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 2025-12-22
Labeling
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 2025-12-22
Labeling
BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE 2025-12-22
Labeling
URSODIOL 2025-11-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 33%
1 drugs
Immunology 33%
1 drugs
Cardiovascular 33%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Merck big-pharma
Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Cardiovascular, Metabolic
AstraZeneca big-pharma
Cardiovascular, Metabolic, Immunology
Boehringer Ingelheim big-pharma
Metabolic, Immunology, Cardiovascular
Novartis big-pharma
Cardiovascular, Immunology